ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Virginia » Rheumatology

Top Rheumatology Prescribers in Virginia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MORRIS WILKENFELD MD

Rheumatology

370

$140K

49
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

37%
prescriptions for brand name drugs

Avg: 24%

$377
Average prescription price

Avg: $132

PHILLIP KEMPF M. D.

Rheumatology

1,098

$399K

192
165 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

36%
prescriptions for brand name drugs

Avg: 24%

$364
Average prescription price

Avg: $132

PHONG NGUYEN MD

Rheumatology

1,965

$658K

241
197 are 65+

6%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

35%
prescriptions for brand name drugs

Avg: 24%

$335
Average prescription price

Avg: $132

JANET LEWIS

Rheumatology

728

$238K

97
52 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$327
Average prescription price

Avg: $132

MALGORZATA GRADZKA M.D.

Rheumatology

681

$201K

97
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$295
Average prescription price

Avg: $132

ROGER LIDMAN M.D.

Rheumatology

1,283

$375K

226
186 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

11%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

30%
prescriptions for brand name drugs

Avg: 24%

$292
Average prescription price

Avg: $132

GREGORY KUJALA MD

Rheumatology

3,159

$909K

427
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

19%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$288
Average prescription price

Avg: $132

HARVEY SCHWARTZ M.D.

Rheumatology

663

$188K

119
92 are 65+

12%
patients receiving schedule two controlled substances

Avg: 4%

9%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$283
Average prescription price

Avg: $132

TAE CHUNG M.D.

Rheumatology

506

$143K

85
75 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

39%
prescriptions for brand name drugs

Avg: 24%

$282
Average prescription price

Avg: $132

SHIKHA SAREBAHI M.D

Rheumatology

496

$137K

115
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$277
Average prescription price

Avg: $132

HERBERT WILSON MD

Rheumatology

714

$189K

108
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$264
Average prescription price

Avg: $132

MEGAN ESHBAUGH D.O.

Rheumatology

390

$99.1K

41
25 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$254
Average prescription price

Avg: $132

DOROTHY NICHOLSON M.D.

Rheumatology

551

$137K

93
68 are 65+

16%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$249
Average prescription price

Avg: $132

KATHLEEN PRICE MD

Rheumatology

1,855

$459K

142
109 are 65+

17%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$247
Average prescription price

Avg: $132

WITOLD TURKIEWICZ M.D.

Rheumatology

1,163

$282K

201
161 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

6%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$242
Average prescription price

Avg: $132

GEORGE MOXLEY M.D.

Rheumatology

1,020

$240K

167
76 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$235
Average prescription price

Avg: $132

MALA MEHTA M.D.

Rheumatology

1,227

$285K

224
189 are 65+

5%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

29%
prescriptions for brand name drugs

Avg: 24%

$233
Average prescription price

Avg: $132

ALFRED DENIO M.D.

Rheumatology

863

$200K

173
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$232
Average prescription price

Avg: $132

ANDRONIKI BILI M.D.

Rheumatology

1,559

$343K

202
142 are 65+

7%
patients receiving schedule two controlled substances

Avg: 4%

12%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$220
Average prescription price

Avg: $132

CATHERINE DANIEL M.D.

Rheumatology

1,605

$346K

198
143 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

7%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$215
Average prescription price

Avg: $132

TRACEY ROBINSON MD

Rheumatology

1,164

$245K

108
86 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

13%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$210
Average prescription price

Avg: $132

DONALD KIMPEL

Rheumatology

346

$71.2K

66
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$206
Average prescription price

Avg: $132

MARIA CHOU MD

Rheumatology

981

$198K

130
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

33%
prescriptions for brand name drugs

Avg: 24%

$201
Average prescription price

Avg: $132

EDWARD TACKEY MD

Rheumatology

835

$168K

146
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$201
Average prescription price

Avg: $132

CAROLINE D'SOUZA M.D.

Rheumatology

647

$128K

98
43 are 65+

0%
patients receiving schedule two controlled substances

Avg: 4%

0%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

20%
prescriptions for brand name drugs

Avg: 24%

$198
Average prescription price

Avg: $132

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank